1-2 of 2
Jeffrey Stavenhagen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD32B, the human inhibitory Fc-γ receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma

Christopher T. Rankin, Maria-Concetta Veri, Sergey Gorlatov, Nadine Tuaillon, Steve Burke, Ling Huang, H. David Inzunza, Hua Li, Shannon Thomas, Syd Johnson, Jeffrey Stavenhagen, Scott Koenig, Ezio Bonvini
Journal: Blood
Blood (2006) 108 (7): 2384–2391.
https://doi.org/10.1182/blood-2006-05-020602
Published: 2006
Includes: Supplemental data
Journal Articles

Rituximab Variants with Re-Engineered Fc with Higher Affinity to Activating Fcγ R Eliminate the Functional Difference between Fcγ R Genotypes.

Wen-Kai Weng, MD, PhD, Jeffrey Stavenhagen, PhD, Scott Koenig, MD, PhD, Ronald Levy, MD
Journal: Blood
Blood (2005) 106 (11): 347.
https://doi.org/10.1182/blood.V106.11.347.347
Published: 2005